ArticleERJ open research2026
Low appendicular muscle mass and the risk of COPD development in people with PRISm.
Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Preserved ratio impaired spirometry (PRISm) is a heterogeneous condition often accompanied by respiratory symptoms and increased mortality, affecting 5-24% of the general population. However, the prevalence of low muscle mass and related clinical characteristics in PRISm remain unknown. This study aimed to: 1) determine the prevalence of low appendicular skeletal muscle index (ASMI) in individuals with PRISm compared with normal spirometry and COPD; 2) describe characteristics of persons with PRISm with low or normal ASMI; and 3) investigate whether low ASMI in PRISm is associated with COPD development. Methods: In the Rotterdam Study, participants were classified as PRISm, COPD, or normal spirometry. Baseline characteristics and body composition (dual-energy radiograph absorptiometry-derived ASMI) were collected. Low ASMI was defined as <7.0 kg·m Results: Among 5487 individuals, Low ASMI prevalence in PRISm was 8%, and was more common than in normal spirometry (4%). Among individuals with PRISm, 49% developed COPD over time. Compared to individuals with normal spirometry and normal ASMI, individuals with PRISm and low ASMI had a sevenfold higher risk of developing COPD adjusted for sex, age, and smoking. Conclusion: Low ASMI was more prevalent in PRISm compared to normal spirometry. PRISm at baseline and smoking were strongly associated with COPD development, with the highest risk in individuals with PRISm and low ASMI, suggesting that low ASMI in PRISm may be a treatable trait requiring clinical attention.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.